By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Becton Dickinson today announced that its board has elected Vincent Forlenza to take over as the company's CEO starting Oct. 1, replacing Edward Ludwig.

Forlenza who joined BD in 1980 is currently president and chief operating officer at BD. He will remain President upon becoming the firm's CEO, BD said. Starting Oct. 1, he also will become a member of the board.

Ludwig will serve as executive chairman of the board starting Oct. 1 continuing through June 2012.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PNAS this week: co-evolutionary signatures of insect hosts and bacterial symbionts, distinct transcript isoforms of high-grade ovarian cancer, and more.

Adam Rutherford discusses genetic genealogy at the Guardian.

Portions of the US 21st Century Cures Act are raising some safety concerns.

David Dobbs writes at Buzzfeed that genomics has delivered little on its promises.